Angiotensinogen (serpin Peptidase Inhibitor, Clade A, Member 8) (AGT) Peptid
AGT
Reaktivität: Säugetier
Wirt: Synthetic
WB, BP, IHC
-
- Target Alle AGT Produkte
- AGT (Angiotensinogen (serpin Peptidase Inhibitor, Clade A, Member 8) (AGT))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Western Blotting (WB), Blocking Peptide (BP), Immunohistochemistry (IHC)
- Sequenz
- IHPFHLVIHN ESTCEQLAKA NAGKPKDPTF IPAPIQAKTS PVDEKALQDQ
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of AGT antibody,
Alternative Names: AGT control peptide, AGT antibody Blocking Peptide, Anti-AGT Blocking Peptide, Angiotensinogen Blocking Peptide, Serpin Peptidase Inhibitor Clade A 8 Blocking Peptide, ANHU Blocking Peptide, SERPINA8 Blocking Peptide
-
Angiotensinogen (serpin Peptidase Inhibitor, Clade A, Member 8) (AGT) peptide (Ovalbumin)
AGT Reaktivität: Human, Maus, Ratte Wirt: Synthetic WB, Imm, SDS
Angiotensinogen (serpin Peptidase Inhibitor, Clade A, Member 8) (AGT) (AA 34-43) peptide (Ovalbumin)AGT Reaktivität: Human Wirt: Synthetic WB, Imm, SDS
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- AGT (Angiotensinogen (serpin Peptidase Inhibitor, Clade A, Member 8) (AGT))
- Synonyme
- ANHU Peptide, SERPINA8 Peptide, AI265500 Peptide, AngI Peptide, AngII Peptide, Aogen Peptide, Serpina8 Peptide, ANRT Peptide, Ang Peptide, PAT Peptide, wu:fb62f06 Peptide, wu:fj87b02 Peptide, zgc:111892 Peptide, AGT Peptide, angt Peptide, ANGT Peptide, angiotensinogen Peptide, angiotensinogen (serpin peptidase inhibitor, clade A, member 8) Peptide, AGT Peptide, Agt Peptide, agt Peptide
- Hintergrund
- AGT, pre-angiotensinogen or angiotensinogen precursor, is expressed in the liver and is cleaved by the enzyme renin in response to lowered blood pressure. The resulting product, angiotensin I, is then cleaved by angiotensin converting enzyme (ACE) to generate the physiologically active enzyme angiotensin II. The protein is involved in maintaining blood pressure and in the pathogenesis of essential hypertension and preeclampsia. Mutations in this gene are associated with susceptibility to essential hypertension, and can cause renal tubular dysgenesis, a severe disorder of renal tubular development. Defects in this gene have also been associated with non-familial structural atrial fibrillation, and inflammatory bowel disease.
- Molekulargewicht
- 53 kDa
-
Sie sind hier:
